MedTrace Logo

Postoperative Pain Control in Total Shoulder Arthroplasty

NCT05068960 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-03-21

No results posted yet for this study

Summary

A double blind, prospective, randomized trial to evaluate postoperative pain, narcotic use, patient satisfaction, and function among shoulder arthroplasty patients receiving interscalene block with and without the addition of liposomal bupivacaine.

Conditions

  • Total Shoulder Arthroplasty

Interventions

DRUG

Liposomal bupivacaine

Addition of liposomal bupivacaine to the interscalene block for extended pain control following total shoulder arthroplasty

DRUG

Bupivacaine

Interscalene block with bupivacaine for pain control following total shoulder arthroplasty

Sponsors & Collaborators

  • Scripps Clinic

    lead OTHER

Principal Investigators

  • Heinz Hoenecke, MD · Scripps Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2025-02-01
Completion
2025-02-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05068960 on ClinicalTrials.gov